Anti-Candida auris activity in vitro and in vivo of micafungin loaded nanoemulsions.
Gabriel Davi MarenaGabriela Corrêa CarvalhoMatheus Aparecido Dos Santos RamosMarlus ChorilliTais Maria BauabPublished in: Medical mycology (2022)
Fungi are becoming increasingly resistant, especially the new strains. Therefore, this work developed nanoemulsions (NE) containing micafungin (MICA), in order to improve its action against infections caused by Candida auris. The NEs were composed by the surfactants polyoxyethylene (20) cetyl ether (Brij 58®)/soy phosphatidylcholine at 10%, sunflower oil/cholesterol at 10% and 80% PBS. The NEs were characterized by Dynamic Light Scattering (DLS). For the microbiological in vitro evaluation the determination of the minimum inhibitory concentration (MIC), ergosterol/sorbitol, time kill and biofilms tests were performed. Additionally, the antifungal activity was also evaluated in a Galleria mellonella model. The same model was used in order to evaluate acute toxicity. The NE showed a size of approximately 42.12 nm, a PDI of 0.289 and a PZ of -3.86 mV. NEM had an average size of 41.29 nm, a PDI of 0.259 and a PZ of -4.71 mV. Finally, both nanoemulsions showed good stability in a storage period of three months. Although NEM did not showed activity in planktonic cells, it exhibited action against biofilm and in the in vivo infection model . In the alternative in vivo model assay it was possible to observe that both, NEM and free MICA at 0.2 mg/L, was effective against the infection, being that NEM presented a better action. Finally, NEM and free MICA showed no acute toxicity up to 4 mg/L. NEM showed the best activities in in vitro in mature antibiofilm and in alternative in vivo models in G. mellonella. Although, NEs showed to be attractive for MICA transport in the treatment of infections caused by C. auris in vitro and in vivo studies with G. mellonella, further studies should be carried out, in mice for example.
Keyphrases
- candida albicans
- liver failure
- oxidative stress
- escherichia coli
- biofilm formation
- staphylococcus aureus
- pseudomonas aeruginosa
- drug delivery
- induced apoptosis
- intensive care unit
- type diabetes
- respiratory failure
- adipose tissue
- high resolution
- mass spectrometry
- drug induced
- cystic fibrosis
- single cell
- aortic dissection
- signaling pathway
- cancer therapy
- acute respiratory distress syndrome
- solid phase extraction
- combination therapy
- light emitting